Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002124147-26-000002
Filing Date
2026-03-25
Accepted
2026-03-25 18:01:42
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1774476099.html 3  
1 FORM 3 wk-form3_1774476099.xml 3 2408
2 EX-24 powerofattorneyrs.htm EX-24 18311
  Complete submission text file 0002124147-26-000002.txt   22146
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190840
BioNTech SE (Issuer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address AN DER GOLDGRUBE 12 MAINZ Germany 55131
Business Address
Staudigl Rudolf (Reporting) CIK: 0002124147 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39081 | Film No.: 26793760